Aflac Incorporated is a provider of supplemental insurance products, operating primarily in the United States and Japan, offering policies that supplement existing health and life insurance coverage across various product lines including cancer, medical, life, accident, and disability. The company distributes its offerings through a diverse network of agencies, banks, and brokers. In the most recent reported quarters, Aflac's EPS performance showed a significant acceleration, moving from $1.56 in Q4 2025 to $1.57 in Q4 2025, followed by a substantial jump to $2.49 in Q3 2025 and $1.78 in Q2 2025, indicating a strong upward trend in the latter half of the reported period. Revenue also demonstrated growth, with Q4 2025 at $4.87 billion and Q3 2025 at $4.41 billion, compared to $4.32 billion in Q4 2025 and $4.32 billion in Q1 2025. The company's beat/miss pattern in EPS was mixed, with misses in Q4 2025 ($1.56 actual vs. $1.62 estimate) and Q4 2025 ($1.57 actual vs. $1.71 estimate), but significant beats in Q3 2025 ($2.49 actual vs. $1.78 estimate) and Q2 2025 ($1.78 actual vs. $1.71 estimate). Historically, Aflac has shown a trajectory of revenue growth, with reported revenues consistently above $4.3 billion in the recent quarters, although EPS performance against estimates has varied, with notable beats in Q2 and Q3 2025. Recent news highlights a divergence in analyst sentiment, with some lowering price targets due to concerns over disability margins and economic uncertainty, while others, like Evercore ISI, have upgraded the stock to Outperform with a significantly raised price target to $236, signaling renewed positive outlook. Investors will be watching for Aflac's ability to sustain its recent EPS acceleration and justify its market valuation in the upcoming quarters, particularly in light of mixed analyst outlooks and potential headwinds in disability margins. Key will be the company's guidance for future quarters and its performance against analyst expectations for Q1 2026, where EPS is estimated at $1.81 and revenue at $4.29 billion.
